NCCN Guidelines Panel Disclosures

Panel Member	Clinical Research Support	Advisory Boards, Speakers Bureau, Expert Witness, or Consultant	Patent, Equity, or Royalty	Other	Date Completed
Jeffrey Allen, MD	None	None	None	None	6/11/2010
James Armitage, MD	None	None	None	None	12/16/2009
Charles L. Bennett, MD, PhD, MPP	None	National Center for Medical Education	None	None	4/13/2010
Douglas W. Blayney, MD	None	Amgen Inc.; Bristol-Myers Squibb Company	None	American Society of Clinical Oncology; Stanford Hospitals and Clinics; University of Michigan	8/10/2010
Spero R. Cataland, MD	None	Amgen Inc.	None	None	12/10/2009
Jeffrey Crawford, MD	Celgene Corporation; Facet Biotech; Hoffman LaRoche	Amgen Inc.; Genentech, Inc.; Medtronic, Inc.; Aggenix AG; Chugai Pharmaceuticals; Ono Pharmaceuticals	None	None	4/29/2010
Mary Dwyer, MS	None	None	None	None	7/15/2010
James M. Foran, MD	Eisai Inc.; Genzyme Corporation; Medarex, Inc.	Celgene Corporation; Sunesis Pharmaceuticals, Inc.	None	None	2/9/2010
Lauren Gallagher, RPh, PhD	None	None	None	None	8/23/2010
Kristina M. Gregory, RN, MSN, OCN	None	None	None	None	8/30/2010
Mark L. Heaney, MD, PhD	None	Genzyme Corporation	None	None	12/4/2009
Maria Ho, PhD	None	None	None	None	7/15/2010
Sally L. Htoy, PharmD	None	None	None	None	1/6/2010
Susan Hudock, BS, PharmD, BCOP	None	None	None	None	7/1/2009
Dwight D. Kloth, PharmD, FCCP, BCOP	None	Amgen Inc.; Eisai Inc.	None	None	4/6/2010
David J. Kuter, MD, DPhil	None	Amgen, Inc; Caremark	None	None	7/1/2009
Gary H. Lyman, MD, MPH, FRCP	Amgen Inc.	Amgen Inc.	None	None	7/29/2009
Joan S. McClure, MS	None	None	None	None	7/18/2010
David Steensma, MD	None	Amgen Inc.; Ortho Biotech Products, L.P.	None	None	8/12/2010
Saroj Vadhan-Raj, MD	Amgen Inc.	Amgen Inc.	None	None	12/16/2009
Peter Westervelt, MD, PhD	None	Celgene Corporation; Novartis Pharmaceuticals Corporation	None	None	10/6/2009
Michael Westmoreland, PharmD	None	Merck & Co., Inc.; Pfizer Inc.	None	None	7/17/2009

NCCN Website Supporters

National Comprehensive Cancer Network

About NCCN